Abstract:Background and purpose: Gene transfer with recombinant non-viral vectors encoding vasodilator proteins, Such as endothelial nitric oxide synthase (eNOS), may be a preferential choice in gene therapy of artery restenosis following angioplasty, stent or anastomosis. However, the transfection rate of a non-viral vector, the harmful effects of eNOS transfection on endothelial cells (EC)and the control release of nitric oxide (NO) have been controversial. We designed the eukaryotic expression vector pcDNA3.1-eNOS to study the regulated expression of eNOS (in the presence of various chemical agents) and to evaluate the exogenous NO effect on EC proliferation in vitro.Methods: The full-length human eNOS cDNA was inserted into the EcoRI cloning site of the pcDNA3.1 expression plasmid and the eNOS direction was tested by restriction enzyme digestion with XhoI to construct recombinant pcDNA3.1-eNOS. After co-transfection of pcDNA3.1-eNOS with pcDNA3.0-EGFP mediated by cationic liposomes into Human umbilical vein endothelial cells (ECV304), the transfection rate and the effect on ECV304 proliferation were calculated by fluorescence microscopy and flowcytometry. eNOS mRNA and protein were detected by reverse transcription-PCR (RT-PCR) and immunofluorescence, respectively. The eNOS activity, NO release and changes of the relevant cells growth curve were assessed after treating the transfected cells with four independent factors including ie Ca2+, L-arginine (L-Arg), Ethylene Diamine Tetraacetic Acid (EDTA) and N-nitro-L-arginine methylester (L-NAME). In addition, we examined the nontransfected cells status by isolated sodium nitroprusside (SNP) treatment.Result: eNOS cDNA was inserted into pcDNA3.1 in die proper direction. RT-PCR analysis showed that pcDNA3.1-eNOS transfected cells could express eNOS mRNA. The rate of eNOS transfection was 39.6 +/- 3.4%. Immunofluorescence staining displayed that subcellular localisation of eNOS was most prominent in plasma membrane and per] nuclear regions of the cell. The eNOS activity of eNOS transfected cells had not increased significantly, whereas, in the presence of Call, L-Arg, EDTA, and L-NAME, the eNOS activity was 96.98 +/- 13.47, 32.57 +/- 6.39, 11.63 +/- 3.02, 15.56 +/- 7.34 U/ml respectively and the NO level was 55.34 +/- 11.19, 9.43 +/- 4.51., 2.63 +/- 1.41, 3.73 +/- 1.65 mmol/L, respectively. Meanwhile, die growth curves of EC shifted. SNP also had obvious growth-inhibiting effects on the cells. Together, the ECV304 growth curve went downward in a NO concentration-dependent manner.Conclusion: Eukaryotic expression vector pcDNA3.1-eNOS was constructed successfully with the ability to express human eNOS mRNA and protein in EC effectively. The activity of eNOS in EC could be regulated by certain exogenous factors. Ca2+ was an important factor promoting NO release and excess NO had a cytotoxic effect on EC in vitro. Controlled release of NO in vivo and polygenic measurements might be considered in more clinical gene therapy studies.

Gene Transfer of Human Endothelial Nitric Oxide Synthase Inhibits Proliferation of Human Vascular Smooth Muscle Cells and the Mechanism

Construction of the Recombinant Human Endothelial Nitric Oxide Synthase Gene Adenovirus and Its Expression in Human Vascular Smooth Muscle Cells

Study on Inhibitation of the Tube Formation by RNA Introduced by Adenovirus by its Interference With and Decrease of VEGF Transcription

Endothelial nitric oxide synthase gene transfected endothelial cells inhibit smooth muscle cell proliferation and platelet aggregation early in vitro

Adenovirus Mediated Gene Transfer of Human Interleukin-10 Inhibits Proliferation of Vascular Smooth Muscle Cells and Its Mechanism

[Inhibition of retrovirus-mediated gene transfer of inducible nitric oxide synthase on proliferation of vascular smooth muscle cell]

[Adenovirus-Mediated Gene Transfer of Rhsg-1 Inhibits Proliferation of Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats].

Effect of Endothelial Nitric Oxide Synthase on Proliferation of Rat Vascular Smooth Muscle Cells from Ballon-Injured Carotid Artery

Effects of Adenovirus-Mediated Endothelial Nitric Oxide Synthase Gene Transfer on Neointimal Proliferation of Rat Carotid Artery after Balloon Injury

Study of Inhibitory Effect and Mechanism of Nitric Oxide on the Proliferation of Vascular Smooth Muscle Cells

Effects of endothelial nitric oxide synthase gene transfection on neointima hyperplasia after vascular injury

Effect of Henos Gene Transfection on Functions of Canine Bone Marrow-Derived Endothelial Progenitor Cell

Effects of Human Growth Arrest-Specific Homeobox Gene Delivery on Proliferation, Migration and Cell Cycle Distribution of Vascular Smooth Muscle Cells

Adenovirus Gene Transfer Of Recombinant Endothelial Nitric Oxide Synthase Enhances Contractile Function In Ventricular Myocytes

Effect of recombinant adenovirus-mediated endostatin-soluble vascular endothelium growth inhibitor fusion gene on corneal neovascularization

Changes in Human Umbilical Vein Endothelial Cells Induced by Endothelial Nitric Oxide Synthase Traffic Inducer

Study on Inhibittonal Effect of Endothelial Nitric Oxide Synthase Gent Transfer on Neointimal Proliferation of Artery after Hal-Ion Injury

Experimental Study of Recombinant Aukaryotic Expression Vector of Human Enos in ECV304 Cells

Experimental Study on Henos Gene Transfecting Canine Bone Marrow-Derived Endothelial Progenitor Cells

The inhibition of antisense RNA retroviral vector of mTOR on proliferation of vascular smooth muscle cells

Inhibitory Effects of Endostatin-Vascular Endothelial Growth Inhibitor Recombinant Adenoviruses on Neovascularization